Effective-Component Compatibility of Bufei Yishen Formula (ECC-BYF) III Inhibits Mucus Hypersecretion by BEAS-2B Cells via miR-146a-5p-Mediated Regulation of the EGFR/MEK/ERK Pathway

Wei Y, Ma J

International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:623-639

Published Date: 10 March 2025